Mortality Trends for Veterans Hospitalized With Heart Failure and Pneumonia Using Claims-Based vs Clinical Risk-Adjustment Variables.


Journal

JAMA internal medicine
ISSN: 2168-6114
Titre abrégé: JAMA Intern Med
Pays: United States
ID NLM: 101589534

Informations de publication

Date de publication:
01 03 2020
Historique:
pubmed: 21 12 2019
medline: 3 11 2020
entrez: 21 12 2019
Statut: ppublish

Résumé

Prior studies have reported declines in mortality for patients admitted to Veterans Health Administration (VA) and non-VA hospitals using claims-based risk adjustment. These apparent mortality reductions may be influenced by changes in coding practices. To compare trends in the VA for 30-day mortality following hospitalization for heart failure (HF) and pneumonia using claims-based and clinical risk-adjustment models. This observational time-trend study analyzed admissions to a VA Medical Center with a principal diagnosis of HF, pneumonia, or sepsis/respiratory failure (RF) with a secondary diagnosis of pneumonia. Exclusion criteria included having less than 12 months of VA enrollment, being discharged alive within 24 hours, leaving against medical advice, and hospice utilization. Admission to a VA hospital from January 2009 through September 2015. The primary outcome was 30-day, all-cause mortality. All models included age and sex. Claims-based covariates included 22 (30) comorbidities for HF (pneumonia). Clinical covariates included vital signs, laboratory values, and ejection fraction. Among the 146 924 HF admissions, the mean (SD) age was 71.6 (11.4) years and 144 502 (98.4%) were men; among the 131 325 admissions for pneumonia, the mean (SD) age was 70.8 (12.3) years and 127 491 (97.1%) were men. Unadjusted 30-day mortality rates were 6.45% (HF) and 11.22% (pneumonia). Claims-based models showed an increased predicted risk of 30-day mortality over time (0.019 percentage points per quarter for HF [95% CI, 0.015 to 0.023]; 0.053 percentage points per quarter for pneumonia [95% CI, 0.043 to 0.063]). Clinical models showed declines or no change in predicted risk (-0.014 percentage points per quarter for HF [95% CI, -0.020 to -0.008]; -0.004 percentage points per quarter for pneumonia [95% CI, -0.017 to 0.008]). Claims-based risk adjustment yielded declines in 30-day mortality of 0.051 percentage points per quarter for HF (95% CI, -0.074 to -0.027) and 0.084 percentage points per quarter for pneumonia (95% CI, -0.111 to -0.056). Models adjusting for clinical covariates attenuated or eliminated these changes for HF (-0.017 percentage points per quarter; 95% CI, -0.039 to 0.006) and for pneumonia (-0.026 percentage points per quarter; 95% CI, -0.052 to 0.001). Compared with the claims-based models, the clinical models for HF and pneumonia more accurately differentiated between patients who died after 30 days and those who did not. Among HF and pneumonia hospitalizations, adjusting for clinical covariates attenuated declines in mortality rates identified using claims-based models. Assessments of temporal trends in 30-day mortality using claims-based risk adjustment should be interpreted with caution.

Identifiants

pubmed: 31860015
pii: 2757530
doi: 10.1001/jamainternmed.2019.5970
pmc: PMC6990854
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

347-355

Subventions

Organisme : HSRD VA
ID : I01 HX002104
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

JAMA. 2012 Apr 4;307(13):1405-13
pubmed: 22474204
Med Care. 2011 Jun;49(6):560-8
pubmed: 21422951
J Am Med Inform Assoc. 2012 Sep-Oct;19(5):859-66
pubmed: 22437073
JAMA Intern Med. 2018 Feb 1;178(2):290-292
pubmed: 29131896
JAMA. 2016 Jul 19;316(3):345-6
pubmed: 27434448
JAMA. 2007 Sep 5;298(9):984-92
pubmed: 17785643
Ann Intern Med. 2016 Aug 2;165(3):153-60
pubmed: 27239794
Ann Intern Med. 2012 Dec 18;157(12):837-45
pubmed: 23247937
N Engl J Med. 2014 Dec 11;371(24):2298-308
pubmed: 25494269
JACC Heart Fail. 2014 Oct;2(5):440-6
pubmed: 25194291
N Engl J Med. 1997 Jan 23;336(4):243-50
pubmed: 8995086
JAMA. 2011 Oct 19;306(15):1669-78
pubmed: 22009099
JAMA Netw Open. 2019 May 3;2(5):e193290
pubmed: 31050779
Circulation. 2007 Mar 27;115(12):1518-27
pubmed: 17353447
N Engl J Med. 2018 Jun 28;378(26):2456-2458
pubmed: 29949490
Crit Care Med. 2015 May;43(5):989-95
pubmed: 25746747
Ann Intern Med. 2014 Dec 2;161(11):765-74
pubmed: 25437404
Health Aff (Millwood). 2019 Jan;38(1):36-43
pubmed: 30615522
Med Care. 2010 Jul;48(7):652-8
pubmed: 20548253
Annu Rev Public Health. 2009;30:313-39
pubmed: 19296778
JAMA Intern Med. 2014 Nov;174(11):1806-14
pubmed: 25201438
Circ Heart Fail. 2011 May;4(3):301-7
pubmed: 21467294
JAMA. 2012 Jul 18;308(3):257-64
pubmed: 22797643
Am J Public Health. 2003 Jul;93(7):1137-43
pubmed: 12835199
Popul Health Metr. 2006 Apr 10;4:2
pubmed: 16606453
Circulation. 2006 Apr 4;113(13):1693-701
pubmed: 16549636
J Am Coll Cardiol. 2010 Jul 27;56(5):362-8
pubmed: 20650356

Auteurs

Gabriella C Silva (GC)

Department of Biostatistics, Brown University School of Public Health, Providence, Rhode Island.

Lan Jiang (L)

Providence VA Medical Center, Providence, Rhode Island.

Roee Gutman (R)

Department of Biostatistics, Brown University School of Public Health, Providence, Rhode Island.

Wen-Chih Wu (WC)

Providence VA Medical Center, Providence, Rhode Island.

Vincent Mor (V)

Providence VA Medical Center, Providence, Rhode Island.
Department of Health Services, Policy and Practice, Brown University School of Public Health, Providence, Rhode Island.

Michael J Fine (MJ)

Center for Health Equity Research and Promotion, Virginia Pittsburgh Healthcare System, Pittsburgh, Pennsylvania.
School of Medicine, Division of General Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Nancy R Kressin (NR)

Center for Healthcare Organization and Implementation Research, Virginia Boston Healthcare System, Boston, Massachusetts.
Boston University School of Medicine, Boston, Massachusetts.

Amal N Trivedi (AN)

Providence VA Medical Center, Providence, Rhode Island.
Department of Health Services, Policy and Practice, Brown University School of Public Health, Providence, Rhode Island.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH